Brief: Oncopeptides Expects Q4 Net Sales Of SEK 18.6 Mln
Jan 16 (Reuters) - Oncopeptides AB ONCO.ST: SAID ON THURSDAY EXPECTS Q4 NET SALES OF SEK 18.6 MLN, INCREASE OF 88% VS YR AGO EXPECTS POSITIVE CASH-FLOW TO OCCUR IN 2027, INSTEAD OF END OF PREV COMMUNICATED 2026 Source text for Workspace: nMFN1bC2Fn Further company coverage: ONCO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy